207 related articles for article (PubMed ID: 23874207)
1. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.
Luo Y; Kaz AM; Kanngurn S; Welsch P; Morris SM; Wang J; Lutterbaugh JD; Markowitz SD; Grady WM
PLoS Genet; 2013; 9(7):e1003552. PubMed ID: 23874207
[TBL] [Abstract][Full Text] [Related]
2. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
3. Dependence receptor TrkC is a putative colon cancer tumor suppressor.
Genevois AL; Ichim G; Coissieux MM; Lambert MP; Lavial F; Goldschneider D; Jarrosson-Wuilleme L; Lepinasse F; Gouysse G; Herceg Z; Scoazec JY; Tauszig-Delamasure S; Mehlen P
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3017-22. PubMed ID: 23341610
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer.
Chen Z; Huang Z; Luo Y; Zou Q; Bai L; Tang G; Wang X; Cao G; Huang M; Xiang J; Yu H
J Transl Med; 2021 Feb; 19(1):73. PubMed ID: 33593392
[TBL] [Abstract][Full Text] [Related]
5. RET is a potential tumor suppressor gene in colorectal cancer.
Luo Y; Tsuchiya KD; Il Park D; Fausel R; Kanngurn S; Welcsh P; Dzieciatkowski S; Wang J; Grady WM
Oncogene; 2013 Apr; 32(16):2037-47. PubMed ID: 22751117
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation and tumor-suppressor behavior of NGFR in human colorectal cancer.
Yang Z; Chen H; Huo L; Yang Z; Bai Y; Fan X; Ni B; Fang L; Hu J; Peng J; Wang L; Wang J
Mol Cancer Res; 2015 Jan; 13(1):107-19. PubMed ID: 25244921
[TBL] [Abstract][Full Text] [Related]
7. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
8. MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles.
Yu M; Carter KT; Makar KW; Vickers K; Ulrich CM; Schoen RE; Brenner D; Markowitz SD; Grady WM
Epigenetics; 2015; 10(9):803-9. PubMed ID: 26186366
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
10. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
12. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
13. Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer.
Pan J; Zhong J; Gan LH; Chen SJ; Jin HC; Wang X; Wang LJ
Tumour Biol; 2011 Aug; 32(4):729-35. PubMed ID: 21523445
[TBL] [Abstract][Full Text] [Related]
14. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells.
Dallol A; Morton D; Maher ER; Latif F
Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.
Zhong X; Zhu Y; Mao J; Zhang J; Zheng S
J Cancer Res Clin Oncol; 2013 Mar; 139(3):485-90. PubMed ID: 23180019
[TBL] [Abstract][Full Text] [Related]
17. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
[TBL] [Abstract][Full Text] [Related]
18. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
20. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
Götze S; Feldhaus V; Traska T; Wolter M; Reifenberger G; Tannapfel A; Kuhnen C; Martin D; Müller O; Sievers S
BMC Cancer; 2009 Dec; 9():447. PubMed ID: 20017917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
